对乙型肝炎核心抗原进行过敏数字ELISA系统的开发
Yuki Nakaya1, Takema Hasegawa2, Yuji Hoshi3
1Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. nakaya.yuki@jichi.ac.jp.
Analytical and bioanalytical chemistry
|January 22, 2026
概括
一个新的数字ELISA检测B型肝炎核心抗原 (HBcAg) 的灵敏度是1000倍. 这一突破为监测慢性乙型肝炎 (CHB) 治疗和预测复发提供了更准确的生物标志物.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 生物技术是生物技术.
背景情况:
- 慢性乙型肝炎 (CHB) 是由乙型肝炎病毒 (HBV) 引起的全球重大健康问题.
- 目前的治疗方法,核胺类型 (NUCs),抑制HBV复制,但不能消除病毒ccccDNA,需要终身治疗,因为复发风险.
- 精确监测ccccDNA活性对于NUC停止至关重要,但现有的HBV生物标志物检测方法缺乏灵敏度,特别是在低度时.
研究的目的:
- 为监测CHB开发一种高度敏感和可靠的生物标志物测定方法,与ccccDNA水平相关联.
- 建立一个数字酶链接免疫吸收试验 (ELISA) 系统,用于检测乙型肝炎核心抗原 (HBcAg).
主要方法:
- 开发一个数字ELISA系统,使用一对针对HBcAg的单克隆抗体.
- 评估系统对HBcAg的灵敏度和检测极限.
- 评估血和血清矩阵对测定灵敏度和特异性的影响.
主要成果:
- 数字ELISA系统实现了HBcAg的检测极限为2.9 pg/mL (58 aM),与传统ELISA相比,敏感度增加了约1000倍.
- 在1%或更低的度下,血和血清矩阵对测定灵敏度没有影响.
- 数字ELISA证明了与HBcAg的特异反应性,即使在生物矩阵的存在下.
结论:
- 为检测HBcAg而开发的高度敏感的数字ELISA系统是CHB管理的一个有前途的工具.
- 这种测定可以使治疗策略的监测更准确,并可能指导NUC停药.
- 需要进一步验证,以确定HBcAg数字ELISA作为CHB治疗评估的可靠生物标志物.
相关概念视频
01:30Hypersensitivities
7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
02:10The Nucleosome Core Particle
14.1K
Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
14.1K
01:12The Nucleosome Core Particle
2.2K
Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their primary aim is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. On the other hand, they must allow polymerase enzymes to access histone-bound DNA during...
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their primary aim is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. On the other hand, they must allow polymerase enzymes to access histone-bound DNA during...
2.2K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219